DOES THE USE OF GNRH ANTAGONIST FOR OPTIMIZING TRANSFER DAY DECREASE SUCCESS IN MODIFIED NATURAL CYCLE FROZEN EMBRYO TRANSFERS? Conference Presentation Mar 22 Written by Margot Allen Kate Devine, Ali Borazjani, Samad Jahandideh, Jeanne O’Brien.Awarded 1st Place Outstanding Paper. PCRS 2023Oral Presentation Margot Allen Previous Previous WHAT HAPPENED NEXT? AN ANALYSIS OF PREGNANCY OUTCOMES IN PATIENTS UNDERGOING FROZEN BLASTOCYST TRANSFER (FBT) FOLLOWING A PREVIOUSLY FAILED CYCLE IN A RANDOMIZED CONTROLLED TRIAL. Next Next A DAY IN THE LIFE OF A REPRODUCTIVE ENDOCRINOLOGIST AND INFERTILITY SUBSPECIALIST-INTEGRATION OR DISSOLUTION?
DOES THE USE OF GNRH ANTAGONIST FOR OPTIMIZING TRANSFER DAY DECREASE SUCCESS IN MODIFIED NATURAL CYCLE FROZEN EMBRYO TRANSFERS? Conference Presentation Mar 22 Written by Margot Allen Kate Devine, Ali Borazjani, Samad Jahandideh, Jeanne O’Brien.Awarded 1st Place Outstanding Paper. PCRS 2023Oral Presentation Margot Allen